NEW YORK, Dec 27 - Lion Bioscience will acquire Trega Biosciences in a deal valued at $35 million, the companies announced Wednesday.

Under the terms of the agreement, Lion will issue new shares out of its authorized capital to acquire all outstanding shares of Trega in a stock-for-stock transaction using Lion's American Depositary Shares.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.